| C-Terminal Fragment, Aβ32–37, Analogues Protect Against Aβ Aggregation-Induced Toxicity S Bansal, IK Maurya, N Yadav, CK Thota, V Kumar, K Tikoo, VS Chauhan, ... ACS Chemical Neuroscience 7 (5), 615-623, 2016 | 36 | 2016 |
| TGFβ drives metabolic perturbations during epithelial mesenchymal transition in pancreatic cancer: TGFβ induced EMT in PDAC MU Rajagopal, S Bansal, P Kaur, SK Jain, T Altadil, CP Hinzman, Y Li, ... Cancers 13 (24), 6204, 2021 | 10 | 2021 |
| Cholecystokinin receptor antagonist improves efficacy of chemotherapy in murine models of pancreatic cancer by altering the tumor microenvironment ZX Malchiodi, H Cao, MD Gay, A Safronenka, S Bansal, RD Tucker, ... Cancers 13 (19), 4949, 2021 | 9 | 2021 |
| Antiplasmodial activity of short peptide-based compounds A Mahindra, RP Gangwal, S Bansal, NE Goldfarb, BM Dunn, ... RSC Advances 5 (29), 22674-22684, 2015 | 8 | 2015 |
| An optimized method for the isolation of urinary extracellular vesicles for molecular phenotyping: detection of biomarkers for radiation exposure CP Hinzman, M Jayatilake, S Bansal, BL Fish, Y Li, Y Zhang, S Bansal, ... Journal of Translational Medicine 20 (1), 199, 2022 | 7 | 2022 |
| Longitudinal metabolic alterations in plasma of rats exposed to low doses of high linear energy transfer radiation T Dissmore, AG DeMarco, M Jayatilake, M Girgis, S Bansal, Y Li, K Mehta, ... Journal of Environmental Science and Health, Part C 39 (2), 219-233, 2021 | 7 | 2021 |
| C-Terminal Fragment, Aβ39–42-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity S Bansal, IK Maurya, N Yadav, CK Thota, V Kumar, K Tikoo, VS Chauhan, ... ACS omega 3 (8), 10019-10032, 2018 | 7 | 2018 |
| Aβ 1–42 C-terminus fragment derived peptides prevent the self-assembly of the parent peptide S Bansal, IK Maurya, K Shenmar, N Yadav, CK Thota, V Kumar, K Tikoo, ... RSC advances 7 (7), 4167-4173, 2017 | 7 | 2017 |
| Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis (NASH) A Rabiee, MD Gay, N Shivapurkar, H Cao, S Nadella, CI Smith, JH Lewis, ... Clinical Pharmacology & Therapeutics, 2022 | 4 | 2022 |
| Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic ACJPS Gurbani Jolly†, Tetyana Duka,†, Narayan Shivapurkar, Wenqiang Chen ... Cancers 15, 2811, 2023 | 3 | 2023 |
| Analysis of the urinary metabolic profiles in irradiated rats treated with Activated Protein C (APC), a potential mitigator of radiation toxicity Shivani Bansal, Sunil Bansal, Amrita Cheema International Journal of Radiation Biology, 2023 | 2 | 2023 |
| Safety and pharmacokinetic assessment of Oral proglumide in those with hepatic impairment CC Hsu, S Bansal, H Cao, CI Smith, AR He, MD Gay, Y Li, A Cheema, ... Pharmaceutics 14 (3), 627, 2022 | 2 | 2022 |
| Urinary metabolomics for the prediction of radiation-induced cardiac dysfunction Y Li, S Bansal, V Sridharan, S Bansal, MM Jayatilake, JA Fernández, ... Metabolites 13 (4), 525, 2023 | 1 | 2023 |
| Synthesis, in vitro Cytotoxicity Evaluation, and Docking Studies of Gloriosine Derivatives as Potential Anticancer Agents B Goel, A Naik, N Tripathi, A Khan, S Bansal, S Bansal, S Kumar Guru, ... ChemistrySelect 8 (32), e202301063, 2023 | | 2023 |
| Tu1322: PHASE 1 STUDY TO TEST SAFETY AND DOSE OF A CHOLECYSTOKININ RECEPTOR ANTAGONIST, PROGLUMIDE, IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) A Rabiee, MD Gay, N Shivapurkar, H Cao, S Nadella, C Smith, JH Lewis, ... Gastroenterology 162 (7), S-1274, 2022 | | 2022 |
| White-Nose Syndrome Disrupts the Splenic Lipidome of Little Brown Bats (Myotis lucifugus) at Early Disease Stages CKRW Evan L. Pannkuk,* Nicole A. S.-Y. Dorville, Shivani Bansal, Sunil ... Journal of Proteome Research, 2022 | | 2022 |
| PHASE 1 STUDY TO TEST SAFETY AND DOSE OF A CHOLECYSTOKININ RECEPTOR ANTAGONIST, PROGLUMIDE, IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) JPS Toosa Rabiee, Martha D. Gay, Narayan Shivapurkar, Hong Cao, Sandeep ... Gastroenterology, 10.1016/S0016-5085(22)63743-0, 2022 | | 2022 |
| Cholecystokinin Receptor Antagonist Decreases Epithelial-to-Mesenchymal Transition and Metastasis in Pancreatic Cancer Microenvironment Z Malchiodi, H Cao, M Gay, A Safronenka, S Bansal, R Tucker, ... PANCREAS 50 (7), 1079-1079, 2021 | | 2021 |
| Cholecystokinin receptor antagonist decreases fibrosis in pancreatic cancer microenvironment to improve uptake and efficacy of chemotherapy ZX Malchiodi, H Cao, M Gay, S Bansal, BA Weinberg, A Cheema, ... Cancer Research 80 (16_Supplement), 5326-5326, 2020 | | 2020 |
| Solid forms of Elafibranor and process of preparation thereof Sunil Bansal, Tushar A Algiwale, Bhuwan Bhaskar Pant, Anil K Tyagi WO Patent WO2020115628A1, 2020 | | 2020 |
